Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIF) Sees Significant Growth in Short Interest

Ortho Regenerative Technologies Inc. (OTCMKTS:ORTIFGet Rating) was the target of a significant increase in short interest in the month of April. As of April 30th, there was short interest totalling 3,100 shares, an increase of 416.7% from the April 15th total of 600 shares. Based on an average daily volume of 2,600 shares, the short-interest ratio is currently 1.2 days.

Separately, Zacks Investment Research cut Ortho Regenerative Technologies from a “buy” rating to a “hold” rating in a research report on Friday, February 4th.

Shares of OTCMKTS:ORTIF opened at $0.19 on Thursday. The business’s fifty day moving average price is $0.19 and its two-hundred day moving average price is $0.25. Ortho Regenerative Technologies has a fifty-two week low of $0.13 and a fifty-two week high of $0.81. The stock has a market capitalization of $6.81 million, a price-to-earnings ratio of -1.50 and a beta of -0.74.

Ortho Regenerative Technologies Company Profile (Get Rating)

Ortho Regenerative Technologies Inc, an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic tissue repair devices to enhance the success rate of sports medicine surgeries in Canada. The company develops Ortho-R, a formulation for rotator cuff repair; and Ortho-M, a biopolymer for bioactive meniscus repair.

Read More

Receive News & Ratings for Ortho Regenerative Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ortho Regenerative Technologies and related companies with MarketBeat.com's FREE daily email newsletter.